Voya Investment Management LLC decreased its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 59.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 256,857 shares of the company's stock after selling 380,880 shares during the period. Voya Investment Management LLC owned 0.16% of Astera Labs worth $15,327,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in ALAB. GAMMA Investing LLC boosted its holdings in Astera Labs by 55.7% in the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after acquiring an additional 284 shares during the last quarter. Sound Income Strategies LLC boosted its stake in shares of Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after purchasing an additional 204 shares during the last quarter. Harbour Investments Inc. increased its position in shares of Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after buying an additional 619 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in Astera Labs during the first quarter worth $48,000. Finally, Hazlett Burt & Watson Inc. raised its stake in Astera Labs by 1,670.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock worth $53,000 after buying an additional 835 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on ALAB shares. Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the company a "buy" rating in a research note on Monday, August 4th. Morgan Stanley boosted their price target on Astera Labs from $155.00 to $200.00 and gave the company an "overweight" rating in a research note on Friday, August 29th. William Blair assumed coverage on shares of Astera Labs in a research report on Thursday, May 22nd. They set an "outperform" rating for the company. Northland Securities lowered shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price objective for the company. in a research note on Tuesday, July 22nd. Finally, Jefferies Financial Group increased their target price on shares of Astera Labs from $95.00 to $130.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $142.00.
Read Our Latest Stock Report on ALAB
Astera Labs Price Performance
NASDAQ ALAB opened at $231.29 on Tuesday. The company has a fifty day moving average price of $157.95 and a 200-day moving average price of $105.12. The firm has a market cap of $38.45 billion, a price-to-earnings ratio of 413.02, a PEG ratio of 5.82 and a beta of 1.46. Astera Labs, Inc. has a 1 year low of $42.80 and a 1 year high of $237.82.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs's quarterly revenue was up 149.5% compared to the same quarter last year. During the same period last year, the company posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.
Insider Buying and Selling at Astera Labs
In related news, COO Sanjay Gajendra sold 280,000 shares of the business's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer directly owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the company's stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director directly owned 385,863 shares in the company, valued at $66,858,482.01. This trade represents a 32.17% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,725,979 shares of company stock valued at $254,102,940 over the last 90 days. 12.50% of the stock is currently owned by corporate insiders.
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.